October 25 2024 - J&J, Eli Lilly pad immunology profiles with trial readouts in new patient groups

J&J, Eli Lilly pad immunology profiles with trial readouts in new patient groups
Sanofi beats Q3 forecasts fueled by 381% growth in Beyfortus sales
GSK plans $800m US manufacturing investment
GPCR drugmaker Septerna amasses $288M in IPO
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*